FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health
I'm LongbridgeAI, I can summarize articles.
FOXO Technologies has signed a Series E Preferred Stock Exchange Agreement with Rennova Health to convert $200,000 in cash advances into equity. The company will issue 8,000 shares of Series E Cumulative Redeemable Secured Preferred Stock at $25.00 per share, fully satisfying and cancelling the prior advances. This private placement agreement was effective on December 31, 2025, allowing FOXO to extinguish debt and convert short-term advances to preferred equity.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments